Background-Atrial fibrillation (AF) is the most common adverse event following coronary artery bypass graft surgery.
A trial fibrillation (AF) is the most common adverse event after cardiac surgery, with a reported incidence of 27% to 40%. 1, 2 Postoperative AF is associated with increased risk of neurological, renal and infectious complications, and increased utilization of healthcare resources. 1, 2 Previously identified clinical predictors of postoperative AF include advanced age, a history of AF or chronic obstructive pulmonary disease, and valve surgery. 1, 3, 4 Although much is known of the mechanisms of AF initiation and maintenance, little is known about the molecular basis of AF susceptibility. 5 Identification of genetic variants associated with postoperative AF may provide important insight into the pathogenesis of AF and may provide new therapeutic strategies for individual patients according to relative risk. 6, 7 Clinical Perspective on p 506
Four high-frequency single nucleotide polymorphisms (SNPs) (rs2200733, rs2220427, rs2634073, and rs10033464) within the 4q25 chromosomal region have been recently associated with AF in ambulatory populations of the European and Chinese descent. 8 These SNPs are in linkage disequilibrium (LD) with each other, precluding implication of a single responsible locus. Although these SNPs currently have no known biological role, they are in proximity to the paired-like homeodomain transcription factor 2 (PITX2) gene which is instrumental in cardiac morphogenesis of the systemic and pulmonary venous inflow tracts. 9, 10 In contrast to ambulatory populations where clinical and genetic predictors of AF have been validated, 11 few studies have attempted to identify genetic variants that independently predict new onset postoperative AF in surgical patient populations. 12 We thus prospectively collected clinical and genomic data from patients undergoing primary coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass at 3 major US cardiovascular centers, to determine whether chromosome 4q25 variants independently predict postoperative AF.
Methods

Description of Study Cohorts
Patients aged 21 to 90 years undergoing primary CABG surgery without planned concurrent valve surgery after August 2001 were enrolled at 2 institutions, Brigham and Women's Hospital and Texas Heart Institute, within a single study-the CABG Genomics Program (http://clinicaltrials.gov/show/NCT00281164). Patients were excluded from enrollment in the CABG Genomics Program for a preoperative hematocrit Ͻ25% or transfusion of leukocyte-rich blood products within 30 days before surgery. Patients who underwent unplanned concurrent valve surgery after consenting were not excluded.
The Vanderbilt Cardiac Surgery Registry (VCSR) prospectively enrolled patients older than 18 years undergoing CABG with or without valve surgery at Vanderbilt University Medical Center from November 1999 until November 2004. The Registry consists of a repository of clinical and laboratory data for use in outcome studies. Study protocols were approved by respective institutional review boards, and participants were enrolled after informed written consent was obtained.
Only patients undergoing primary CABG surgery using cardiopulmonary bypass, with or without concurrent valve surgery, were included in the final analyses. Analysis was also restricted to subjects self-reporting 4 white grand-parental ancestries, to avoid potential population stratification.
Data and End-Point Collection
At each site, data were collected during primary hospitalization using study-specific case report forms recording patient demographics, perioperative risk factors, medications, and postoperative outcomes obtained from patient interview and medical records, and staff interviews. Trained medical record data abstractors reviewed the medical records of all subjects. Postoperative AF was defined as the occurrence of AF identified from nursing, physician, and perioperative ECG records, during the postoperative period of the primary hospitalization defined as the duration of contiguous hospitalization in the same institution as the surgery occurred. No formal or informal trials of prophylaxis of AF were conducted during the study period at any institution. Treatment of AF was not specified by this study.
In the discovery cohort comprising patients from the CABG Genomics Program, 1583 subjects recruited from commencement to December 2006. Subjects were excluded if they had one or more of the following exclusions: did not undergo CABG surgery with cardiopulmonary bypass (nϭ41), underwent emergency surgery (nϭ6), were not self-reported white (nϭ240), were in AF on hospital admission or subsequently underwent a Maze procedure (nϭ17) or lacked genotypes or phenotyping data (nϭ315), yielding 959 analyzed patients.
In the validation cohort comprising patients from the VCRS, 1288 subjects were recruited during the study period. Subjects were excluded if they had one or more of the following exclusions: did not undergo CABG surgery with cardiopulmonary bypass (nϭ530), underwent emergency surgery (nϭ134), were not self-reported white (nϭ92), were in AF on hospital admission or subsequently underwent a Maze procedure (nϭ104) or lacked genotypes or phenotyping data (nϭ259), yielding 494 analyzed patients.
Genotyping
SNPs between chromosome 4 positions 111 750 000 to 112 075 000 (B36 assembly) encompassing the originally identified region and PITX2, with a minor allele frequency Ͼ5% in the HapMap Caucasian population were identified. 13, 14 Fifty-one "tagging" SNPs that described 98.2% of the variation within the locus at an r 2 of 0.8, in the 276 HapMap-identified SNPs were identified using HaploView software (version 4.0) 15 and were genotyped in the CABG Genomics cohort. Three SNPs identified by DECODE 8 or associated with postoperative AF in the discovery cohort (rs2200733, rs10033464, and rs13143308) were validated in the VCSR validation cohort.
DNA was extracted from white blood cells using standard procedures. Genotyping was performed with either the Golden Gate assay using an Illumina Bead Station 500G system (Illumina, San Diego, Calif) or the iPLEX Gold assay using a Sequenom MassArray system (Sequenom, San Diego, Calif), in accordance with the manufacturers' standard recommendations. Analysis of the Illumina raw data were done with the clustering algorithm of the Illumina BeadStudio software and individual examination of all intensity plots with manual curation of genotype calls. Sequenom raw data were analyzed with the SpectroTyper 3.4 software (Sequenom). Spectra and cluster plots were checked by visual inspection of intensity plots with manual curation of genotype calls.
Statistical Analysis
Categorical and continuous demographic characteristics were compared between groups with Pearson 2 and Wilcoxon rank sum tests, respectively. Two clinical models relating perioperative and demographic variables to the occurrence of postoperative AF were used. The postoperative AF risk index of Mathew et al, 1 derived from a large multi-institutional cohort, was used to generate an AF risk score for each patient. Patients did not have records of nonsteroidal antiinflammatory use or potassium supplementation, necessary for calculation of the score, so these variables were removed from the scoring. In addition, we separately derived a multivariable logistic regression model of the occurrence of postoperative AF for VCSR participants and CABG Genomics participants, using forward and backwards stepwise logistic regression with entry and exit probability values of 0.20 and 0.05, respectively. Gender and institution were forced into the model to maximize nongenetic model performance. There was very high agreement between the AF risk score and the cohort-derived models, for both cohorts, when assessed using Spearman rank correlation.
PLINK (version 1.01) 16 and SAS (version 9.1.3, SAS Institute, Cary, NC) were used for genetic analysis. Hardy-Weinberg equilibrium was evaluated using an exact test. After application of genotype quality control criteria, univariate analyses were carried out for each SNP to test the null hypothesis of no association between marker polymorphism and postoperative AF, based on allelic, dominant, recessive and trend genetic models. Unadjusted odds ratio (OR) of every SNP marker for postoperative AF were estimated using unconditional logistic regression. Tests of significance are reported as the empirical family-wise probability values based on permuting case/control status using permutation methods implemented in PLINK. Heterogeneity in OR estimates was examined across age groups, self-reported Northern versus Southern European origin, gender, institution, history of AF, genotyping plate, and discovery versus validation cohort, using Breslow-Day testing and estimating empirical association probability values based on stratumconstrained permutation.
Potential population stratification between Northern versus Southern European origins was examined using SNPs within the lactase gene (LCT) known to vary in frequency along a north-south cline (rs182549, rs2322659, rs3754689, rs3769005, rs4954490, and rs4988235). The results did not show significant heterogeneity; therefore, we performed a pooled analysis across these factors. Family-wise error rates were estimated for 45 SNP comparisons within each model by permutation.
LD blocks were first derived in Haploview (version 4.1) using default criteria for the 4q25 region surrounding the most significant 7 SNPs. Phased haplotypes for individuals were assigned by PLINK directly, and Omnibus tests were conducted to assess the overall association between haplotype block and the postoperative AF phenotype. OR for risk of postoperative AF for each haplotype were estimated using logistic regression, referred to the major haplotype. Specific haplotypes within the blocks were then assessed for association with postoperative AF, based on dominant, recessive, and additive genetic models. Tests of significance are reported as the empirical family-wise probability values as in SNP association. Improvement in risk prediction by addition of genotype information to the cohort-specific model was assessed using the area under the receiver operating characteristic; the U statistic was then estimated to significance of change in area. In addition, improvement in prediction was also assessed by reclassification between risk classes using integrated discrimination improvement 17 implemented in the R package Hmisc (http://biostat.mc.vanderbilt.edu/twiki/bin/view/ main/hmisc).
Results
Discovery Cohort
Characteristics of the discovery and validation cohorts, stratified by the occurrence of postoperative AF, are shown in Table 1 . In the CABG Genomics discovery cohort (Nϭ959), postoperative AF was observed in 289 subjects (30.1%) without interinstitutional difference in AF rate. Postoperative AF was associated with older age, a prior history of AF, hypertension and low left ventricular ejection fraction. Operative characteristics associated with postoperative AF were the use of intraoperative inotropes but not the number of coronary artery bypass grafts performed, the site of venous cannulation or the operation performed. The modified AF Risk index was significantly higher in the patients with postoperative AF than those not experiencing AF (20Ϯ9 versus 16Ϯ10; PϽ10 Ϫ9 ). A multivariable logistic model of the occurrence of postoperative AF, derived from these data, confirmed older age and prior AF to be liabilities for postoperative AF, and postoperative "statin" use to be associated with reduced risk of postoperative AF (Table 2) . Postoperative AF most commonly had its onset on postoperative days 2 (17.9%), 3 (33.9%), 4 (21.9%), or 5 (10.6%). Only 5.6% of patients had their first onset of AF beyond postoperative day 7.
One SNP failed genotyping; all remaining SNPs passed filtering by genotyping call rate Ͼ95% and manual curation and the absence of significant deviations from HardyWeinberg equilibrium (PϽ0.001 in controls) or nonrandom missingness. Five SNPs had an observed minor allele frequency Ͻ2.5% and were excluded from further analysis, and thus a total of 45 SNPs were used (Table 3) . Thirty samples with Ͼ10% genotyping failure were excluded. Thus, 45 SNPs in the 4q25 chromosomal region were evaluated in the CABG Genomics cohort (Table 3 ). Significant pairwise LD was present in the region (Figure) , consistent with LD structure observed in the HapMap Caucasian cohort and the European populations used in the original report. 8 Within the discovery cohort, 7 4q25 SNPs (rs4626276, rs2634073, rs2634071, rs212998, rs2200733, rs13143308, and rs2220427) were associated with postoperative AF when accounting for clinical covariates, using the modified AF risk index 1 and the cohort-derived clinical models, specifically including age, a history of AF and surgical procedure, and other covariates (Table 3) . However, the previous association of SNP rs10033464 with AF in ambulatory populations was not seen for postoperative AF. These associations were consistent with both additive and dominant genetic models. Additive ORs for the 7 associated 4q25 SNPs ranged between 1.57 and 2.17 (P value 8.0ϫ10
Ϫ4 to 3.4ϫ10 Ϫ6 ) in the discovery cohort. Demographic variables, notably age and a prior history of AF did not stratify ORs for SNP effects. Specifically, the effect of rs2200733 was not stratified by age (Pϭ0.41) or a prior history of AF (Pϭ0.30). The observed associations survived correction for family-wise error. Observed associations for all SNPs examined are given in the Supplementary material.
Within the discovery cohort, the addition of rs2200733 genotype status improved the area under the receiver operating characteristic from 0.702 to 0.720 (Pϭ2.7ϫ10 Ϫ11 ). The addition of rs13143308 genotype status improved the area under the receiver operating characteristic from 0.702 to 0.719 (PϽ6.1ϫ10 Ϫ9 ). Furthermore, correct classification of AF status was improved by the addition of rs2200733 genotype (Pϭ5.3ϫ10 Ϫ5 ) and by the addition of rs1314408 genotype (Pϭ6.6ϫ10 Ϫ5 ) when assessed using integrated discrimination improvement. Furthermore, we examined for reclassification of individuals between risk classes by the addition of genotype. Defining risk classes as those with cohort-specific model risk less than or greater than the overall observed risk of AF in the discovery cohort, we observed 70 individuals who were correctly reclassified from the incorrect risk group to the correct risk group, and 52 individuals who were incorrectly reclassified from the correct risk group to the incorrect risk group, by the addition of genotype to the model, for a net gain of 18 correct reclassifications.
Validation Cohort
In the VCSR validation cohort (Nϭ494), postoperative AF was observed in 151 subjects (30.6%). VCSR patients who developed postoperative AF were more likely to be older, be of male gender, and have a prior history of AF or pulmonary disease and undergo combined valve and CABG surgery. The male gender risk was driven by a higher incidence of valve surgery in males. Preoperative diuretic use and intraoperative inotrope use were significant associated with postoperative AF, perhaps reflecting more severe myocardial disease. Postoperative ␤-blocker use was not significantly different between patients who developed postoperative AF and those who remained in sinus rhythm. The modified postoperative AF Risk index 1 was significantly higher in the patients with postoperative AF than those not experiencing postoperative AF (20Ϯ10 versus 11Ϯ8; PϽ0.0001). After adjustment for multiple comparison and clinical covariates, specifically including age, a history of AF and surgical procedure, rs2200733, and rs13143308 were significantly associated with postoperative AF (rs2200733: OR, 1.97; 95% CI, 1.24 to 3.15; rs13143308: OR, 1.76; 95% CI, 1.23 to 2.52). There was no evidence for heterogeneity of odds ratios between the 2 cohorts.
Within the validation cohort, the addition of rs2200733 genotype status improved the area under the receiver operating characteristic from 0.731 to 0.740 (Pϭ1.3ϫ10 Ϫ7 ). The addition of rs13143308 genotype status improved the area under the receiver operating characteristic from 0.731 to 0.743 (Pϭ7.6ϫ10 Ϫ5 ). Correct classification of AF status was improved by the addition of rs2200733 genotype (Pϭ0.027) or by the addition of rs1314408 genotype (Pϭ0.005) when assessed using integrated discrimination improvement.
There was a strong haplotype dependence of the associations, consistent with regional block structure ( Figure) and the previously described haplotype structure. 8 A single haplotype described the risk alleles of all 7 associated SNPs in the discovery cohort (Table 4) ; with observed haplotype distribution for nominal and ordinal data. BMI indicates body mass index; LV, left ventricle; NIDDM, non-insulin-dependent diabetes mellitus; IDDM, insulin-dependent diabetes mellitus; CPB, cardiopulmonary bypass; HMG-CoA, 3-hydroxy-3-methyl-glutaryl-CoA reductase; ACE, angiotensin-converting enzyme.
frequencies of 15.3% in affected individuals and 9.0% in unaffected individuals. Haplotype associations were present after accounting for clinical covariates using both clinical models and survived correction for family-wise error. There was no observed association between postoperative AF and SNPs within 91Kbp of the PITX2 gene.
Discussion
AF is the most frequently occurring arrhythmia both in ambulatory and postcardiac surgical patients and is associated with significant morbidity. There is strong evidence for heritability of ambulatory AF, 18 and variation in potassium and sodium channel genes has been associated with AF in ambulatory populations. 19 -22 However, these mutations are rare and are predominantly limited to family kindreds. Two common SNPs, rs2200733 and rs13143308, associated with the 4q25 chromosomal locus define a haplotype that has recently been associated with AF. 8 The haplotype identified by rs2200733 was found to confer a relatively higher risk (OR, 2.14) of AF or atrial flutter, whereas the haplotype identified by rs13143308 conferred a more modest risk increase (OR, 1.75) compared with the common sequence. Models are additionally adjusted for gender, institution, cardiopulmonary bypass duration, and 3-hydroxy-3-methylglutaryl-CoA reductase use in the discovery cohort and additionally adjusted for gender and cardiopulmonary bypass duration in the validation cohort. Models are adjusted for age, gender, prior AF, institution, surgical procedure, cardiopulmonary duration, and 3-hydroxy-3-methyl-glutaryl-CoA reductase use in the discovery cohort and adjusted for age, gender, prior AF, surgical procedure, and cardiopulmonary bypass duration in the validation cohort.
*Family-wise empirical P value is corrected for multiple comparisons.
The functional role of the 4q25 variants in postoperative AF have yet to be elucidated. We found that variants in the 4q25 locus are independently associated with postoperative AF after cardiac surgery. This finding supports the original findings of Gudbjartsson et al 8 in ambulatory patients and extends their findings to the postoperative period, with its marked proinflammatory milieu. This is perhaps surprising, given the numerous perturbations of electrolyte and organ homeostasis and necessary surgical pericardotomy. However, it argues strongly for a common biological mechanism in both populations. Furthermore, the association between the 4q25 locus and new onset postoperative AF remains significant even after accounting for patients with a prior history of AF. The addition of genotype to the clinical model derived risk class, improves overall prediction by correctly reclassifying 7.3% of patients, but at cost of incorrectly reclassifying 5.4% of patients. The overall value of genotype information to clinicians, by reclassification of individuals to risk classes, remains to be determined.
Although the potential mechanism of action of the genetic locus identified by the 2 noncoding SNPs is unknown, and may be mediated through effects of distant genes, it is interesting to note that the closest gene, located approximately 90 kb centromeric, is the transcription factor, PITX2. 8 Mouse PITX2 knockouts have demonstrated a critical role for one isoform, PITX2c, in left-right asymmetry, specifically the development of the left atrium. 10, 23 Loss of PITX2c leads to right atrial isomerization and a failure to suppress a default pathway for sinus node formation in the left atrium of the embryo. PITX2c has been demonstrated to be necessary for the development of the pulmonary myocardium, or the sleeve of cardiomyocytes extending from the left atrium into the initial portion of the pulmonary vein. 9 Clinical and animal studies have demonstrated that ectopic foci of electric activity arising from within the pulmonary veins and posterior left atrium play a substantial role in initiating and maintaining AF. Furthermore, electric isolation of the pulmonary veins and left atrial region is the goal of catheter ablation procedures that increasingly have been used to treat AF in the last decade. Additionally, the candidate gene ENPEP, lying Ϸ300kbp centromeric encodes glutamyl aminopeptidase that Figure. Haplotype block structure of the 45 successfully typed 4q25 SNPs in the CABG Genomics discovery cohort. Increasing correlation (r 2 ) between intersecting SNPs is reflected in increasing darker shading within each intersecting square. Correlations and block structure were estimated using HaploView 4.0. 15 Negative log probability value of the association of each SNP with postoperative AF for an additive genetic model adjusted for clinical covariates is shown. ORs and tests of association are adjusted for the cohort-specific clinical model, using an additive genetic model. The haplotype encompasses the following SNPs: rs2200733, rs13143308, rs10033464. Global haplotype association P valueϭ4.2ϫ10
Ϫ5
. *Family-wise empirical P value corrected for multiple comparisons. Haplotypes with overall cohort frequencies of Ͻ1% were not considered. metabolizes angiotensin II, an important regulator of blood pressure implicated in the genesis of AF. 24 An alternative positional candidate is the 99 amino acid hypothetical protein, LOC729065 25 that lies within the associated haplotype block, but to-date has not been demonstrated to be expressed in human or animal cardiac tissue. SNPs with the best association with postoperative AF lie in the near upstream region and first estimated intron of LOC729065. Our findings do not directly support an association of postoperative AF with PITX2 or other gene. The associated 4q25 SNPs are not in LD with coding or identified regulatory SNPs of the PITX2 gene (Figure) . Furthermore, a strong recombination point lies between the PITX2 gene and the AF-associated SNPs. It is possible that one or more of the identified, or as yet unidentified, SNPs regulate transcription of a gene instrumental in the genesis of AF, but this is currently unknown.
This study is limited by the relatively small sizes of the surgical populations we used. Although the cohorts are likely underpowered for rigorous identification of associations by genome-wide genotyping techniques, surgical populations with detailed phenotyping of AF or other adverse outcomes are rarely available. However, they examine important public health issues in an increasingly aged population.
In conclusion, genetic variants in the 4q25 region are independently associated with an increased risk of postoperative AF. These findings delineate an important genetic role in the etiology of postoperative AF and provide a detailed genomic landscape in which to examine biological mechanisms.
